Health and Healthcare

GlaxoSmithKline (GSK) Take More Heat

Now that the FDA has forced GlaxoSmithKline (GSK) to put a "black label" on its diabetes drug Avandia, the competition is going for a coup de grace.

Takeda Pharmaceutical Co Ltd said on Thursday it was planning a major U.S. advertising campaign for diabetes drug Actos — one day after a new safety warning was issued on rival product Avandia, according to Reuters. The news service adds "the ads will run in 82 local newspapers and in several news weeklies, starting on Friday, under the headline "Actos has been shown to lower blood sugar without increasing your risk of having a heart attack or stroke.".

Never let it be said that the drug company executives are nice people.

Douglas A. McIntyre

Take Charge of Your Retirement: Find the Right Financial Advisor For You in Minutes (Sponsor)

Retirement planning doesn’t have to feel overwhelming. The key is finding professional guidance—and we’ve made it easier than ever for you to connect with the right financial advisor for your unique needs.

Here’s how it works: 

1️ Answer a Few Simple Questions

Tell us a bit about your goals and preferences—it only takes a few minutes!

2️ Get Your Top Advisor Matches

This tool matches you with qualified advisors who specialize in helping people like you achieve financial success.

3️ Choose Your Best Fit

Review their profiles, schedule an introductory meeting, and select the advisor who feels right for you.

Why wait? Start building the retirement you’ve always dreamed of. Click here to get started today!

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.